Login Register Cart 0
Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

The Use of Fibrin-based Tissue Adhesives for Breast in Reconstructive and Plastic Surgery

Author(s): Kuo Chen*, Mikhail Y. Sinelnikov, Vladimir N. Nikolenko, Igor V. Reshetov, Yu Cao, Zhi Li, Ekaterina V. Kochurova, Svetlana N. Nikolenko, Marco Avila-Rodríguez, Siva G. Somasundaram, Cecil E. Kirkland and Gjumrakch Aliev

Volume 19, Issue 32, 2019

Page: [2985 - 2990] Pages: 6

DOI: 10.2174/1568026619666191112101448

Price: $65

Abstract

Background: Breast plastic surgery is a rapidly evolving field of medicine. The modern view of surgical trends reflects the desire to minimize complications and introduce advanced technologies. These always will be priorities for surgeons. Reconstructive surgery, a branch of plastic surgery focusing on restoration of lost functional and aesthetic component, seeks to enhance psychological rehabilitation and improves the quality of life, as well as aesthetic recovery.

Objective: This review addresses the action of fibrin agents and their effect on the quality of surgical hemostasis.

Discussion and Conclusion: The fundamental goals for the surgeon are to perform a minimally traumatic intervention and to prevent any form of complication. Achieving complete hemostasis is an intraoperative necessity. Timely prevention of bleeding and hemorrhagic phenomena can affect not only the outcome of the operation, but also the incidence of postoperative complications. Topics include the integrity of microvascular anastomoses, tissue adhesion, and the incidence of seromas and hematomas associated with fibrin glue usage. The literature on fibrin adhesives with respect to prevention of postoperative complications, and the effectiveness with active drainage also are analyzed.

Keywords: Breast, Fibrin glue, Reconstruction, Aesthetics, Plastic surgery, Fibrinogen.

« Previous Next »
Graphical Abstract

[1]
Jackson, M.R. Fibrin sealants in surgical practice: An overview. Am. J. Surg., 2001, 182(2)(Suppl.), 1S-7S.
[http://dx.doi.org/10.1016/S0002-9610(01)00770-X] [PMID: 11566470]
[2]
Saltz, R.; Sierra, D.; Feldman, D.; Saltz, M.B.; Dimick, A.; Vasconez, L.O. Experimental and clinical applications of fibrin glue. Plast. Reconstr. Surg., 1991, 88(6), 1005-1015.
[http://dx.doi.org/10.1097/00006534-199112000-00009] [PMID: 1946751]
[3]
Spotnitz, W.D. Fibrin sealant: past, present, and future: a brief review. World J. Surg., 2010, 34(4), 632-634.
[http://dx.doi.org/10.1007/s00268-009-0252-7] [PMID: 19820991]
[4]
Dohan, D.M.; Choukroun, J.; Diss, A.; Dohan, S.L.; Dohan, A.J.; Mouhyi, J.; Gogly, B. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2006, 101(3), e37-e44.
[http://dx.doi.org/10.1016/j.tripleo.2005.07.008] [PMID: 16504849]
[5]
Toriumi, D.M.; Chung, V.K.; Cappelle, Q.M. Surgical adhesives in facial plastic surgery. Otolaryngol. Clin. North Am., 2016, 49(3), 585-599.
[http://dx.doi.org/10.1016/j.otc.2016.02.012] [PMID: 27267012]
[6]
Saltz, R.; Toriumi, D.M. Tissue glues in cosmetic surgery; Quality Medical Publishing Inc: St. Louis, 2004.
[7]
Lerner, R.; Binur, N.S. Current status of surgical adhesives. J. Surg. Res., 1990, 48(2), 165-181.
[http://dx.doi.org/10.1016/0022-4804(90)90209-K] [PMID: 2406505]
[8]
Nervi, C.; Gamelli, R.L.; Greenhalgh, D.G.; Luterman, A.; Hansbrough, J.F.; Achauer, B.M.; Gomperts, E.D.; Lee, M.; Navalta, L.; Cruciani, T.R. A multicenter clinical trial to evaluate the topical hemostatic efficacy of fibrin sealant in burn patients. J. Burn Care Rehabil., 2001, 22(2), 99-103.
[http://dx.doi.org/10.1097/00004630-200103000-00003] [PMID: 11302613]
[9]
Rousou, J.; Levitsky, S.; Gonzalez-Lavin, L.; Cosgrove, D.; Magilligan, D.; Weldon, C.; Hiebert, C.; Hess, P.; Joyce, L.; Bergsland, J. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study. J. Thorac. Cardiovasc. Surg., 1989, 97(2), 194-203.
[PMID: 2464722]
[10]
Lowe, J.; Luber, J.; Levitsky, S.; Hantak, E.; Montgomery, J.; Schiestl, N.; Schofield, N.; Marra, S. Evaluation of the topical hemostatic efficacy and safety of TISSEEL VH S/D fibrin sealant compared with currently licensed TISSEEL VH in patients undergoing cardiac surgery: a phase 3, randomized, double-blind clinical study. J. Cardiovasc. Surg. (Torino), 2007, 48(3), 323-331.
[PMID: 17505437]
[11]
Fischer, C.P.; Wood, C.G.; Shen, J.; Batiller, J.; Hart, J.C.; Patel, B.; Albala, D.M. A randomized trial of aprotinin-free fibrin sealant versus absorbable hemostat. Clin. Appl. Thromb. Hemost., 2011, 17(6), 572-577.
[http://dx.doi.org/10.1177/1076029611404212] [PMID: 21873356]
[12]
Schwartz, M.; Madariaga, J.; Hirose, R.; Shaver, T.R.; Sher, L.; Chari, R.; Colonna, J.O., II; Heaton, N.; Mirza, D.; Adams, R.; Rees, M.; Lloyd, D. Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch. Surg., 2004, 139(11), 1148-1154.
[http://dx.doi.org/10.1001/archsurg.139.11.1148] [PMID: 15545559]
[13]
Wang, G.J.; Hungerford, D.S.; Savory, C.G.; Rosenberg, A.G.; Mont, M.A.; Burks, S.G.; Mayers, S.L.; Spotnitz, W.D. Use of fibrin sealant to reduce bloody drainage and hemoglobin loss after total knee arthroplasty: a brief note on a randomized prospective trial. J. Bone Joint Surg. Am., 2001, 83(10), 1503-1505.
[http://dx.doi.org/10.2106/00004623-200110000-00007] [PMID: 11679600]
[14]
Wang, G.J.; Goldthwaite, C.A., Jr; Burks, S.G.; Spotnitz, W.D. Experience improves successful use of fibrin sealant in total knee arthroplasty: implications for surgical education. J. Long Term Eff. Med. Implants, 2003, 13(5), 389-397.
[http://dx.doi.org/10.1615/JLongTermEffMedImplants.v13.i5.40] [PMID: 14649577]
[15]
Wang, G.J.; Goldthwaite, C.A., Jr; Burks, S.; Crawford, R.; Spotnitz, W.D. Fibrin sealant reduces perioperative blood loss in total hip replacement. J. Long Term Eff. Med. Implants, 2003, 13(5), 399-411.
[http://dx.doi.org/10.1615/JLongTermEffMedImplants.v13.i5.50] [PMID: 14649578]
[16]
Levy, O.; Martinowitz, U.; Oran, A.; Tauber, C.; Horoszowski, H. The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. J. Bone Joint Surg. Am., 1999, 81(11), 1580-1588.
[http://dx.doi.org/10.2106/00004623-199911000-00010] [PMID: 10565650]
[17]
Schenk, W.G., III; Burks, S.G.; Gagne, P.J.; Kagan, S.A.; Lawson, J.H.; Spotnitz, W.D. Fibrin sealant improves hemostasis in peripheral vascular surgery: a randomized prospective trial. Ann. Surg., 2003, 237(6), 871-876.
[http://dx.doi.org/10.1097/01.SLA.0000071565.02994.DA] [PMID: 12796584]
[18]
Taylor, L.M., Jr; Mueller-Velten, G.; Koslow, A.; Hunter, G.; Naslund, T.; Kline, R.; Beriplast, P. Prospective randomized multicenter trial of fibrin sealant versus thrombin-soaked gelatin sponge for suture- or needle-hole bleeding from polytetrafluoroethylene femoral artery grafts. J. Vasc. Surg., 2003, 38(4), 766-771.
[http://dx.doi.org/10.1016/S0741-5214(03)00474-9] [PMID: 14560228]
[19]
Chalmers, R.T.A.; Darling Iii, R.C.; Wingard, J.T.; Chetter, I.; Cutler, B.; Kern, J.A.; Hart, J.C. Randomized clinical trial of tranexamic acid-free fibrin sealant during vascular surgical procedures. Br. J. Surg., 2010, 97(12), 1784-1789.
[http://dx.doi.org/10.1002/bjs.7235] [PMID: 20730858]
[20]
Saha, S.P.; Muluk, S.; Schenk, W., III; Burks, S.G.; Grigorian, A.; Ploder, B.; Presch, I.; Pavlova, B.G.; Hantak, E. Use of fibrin sealant as a hemostatic agent in expanded polytetrafluoroethylene graft placement surgery. Ann. Vasc. Surg., 2011, 25(6), 813-822.
[http://dx.doi.org/10.1016/j.avsg.2010.12.016] [PMID: 21514114]
[21]
Saha, S.P.; Muluk, S.; Schenk, W., III; Dennis, J.W.; Ploder, B.; Grigorian, A.; Presch, I.; Goppelt, A. A prospective randomized study comparing fibrin sealant to manual compression for the treatment of anastomotic suture-hole bleeding in expanded polytetrafluoroethylene grafts. J. Vasc. Surg., 2012, 56(1), 134-141.
[http://dx.doi.org/10.1016/j.jvs.2012.01.009] [PMID: 22633423]
[22]
Spotnitz, W.D. Hemostats, sealants, and adhesives: a practical guide for the surgeon. Am. Surg., 2012, 78(12), 1305-1321.
[PMID: 23265118]
[23]
Maisano, F.; Kjaergård, H.K.; Bauernschmitt, R.; Pavie, A.; Rábago, G.; Laskar, M.; Marstein, J.P.; Falk, V. TachoSil surgical patch versus conventional haemostatic fleece material for control of bleeding in cardiovascular surgery: a randomised controlled trial. Eur. J. Cardiothorac. Surg., 2009, 36(4), 708-714.
[http://dx.doi.org/10.1016/j.ejcts.2009.04.057] [PMID: 19595605]
[24]
Frilling, A.; Stavrou, G.A.; Mischinger, H.J.; de Hemptinne, B.; Rokkjaer, M.; Klempnauer, J.; Thörne, A.; Gloor, B.; Beckebaum, S.; Ghaffar, M.F.; Broelsch, C.E. Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial. Langenbecks Arch. Surg., 2005, 390(2), 114-120.
[http://dx.doi.org/10.1007/s00423-005-0543-x] [PMID: 15723234]
[25]
Fischer, L.; Seiler, C.M.; Broelsch, C.E.; de Hemptinne, B.; Klempnauer, J.; Mischinger, H.J.; Gassel, H.J.; Rokkjaer, M.; Schauer, R.; Larsen, P.N.; Tetens, V.; Büchler, M.W. Hemostatic efficacy of TachoSil in liver resection compared with argon beam coagulator treatment: an open, randomized, prospective, multicenter, parallel-group trial. Surgery, 2011, 149(1), 48-55.
[http://dx.doi.org/10.1016/j.surg.2010.02.008] [PMID: 20385397]
[26]
Siemer, S.; Lahme, S.; Altziebler, S.; Machtens, S.; Strohmaier, W.; Wechsel, H.W.; Becker, H. Efficacy and safety of TachoSil® as haemostatic treatment versus standard suturing in kidney tumour resection: a randomised prospective study. Eur. Urol., 2007, 52(4), 1156-1163.
[http://dx.doi.org/10.1016/j.eururo.2007.04.027]
[27]
Gärtner, R.; Jensen, M.B.; Kronborg, L.; Ewertz, M.; Kehlet, H.; Kroman, N. Self-reported arm-lymphedema and functional impairment after breast cancer treatment--a nationwide study of prevalence and associated factors. Breast, 2010, 19(6), 506-515.
[http://dx.doi.org/10.1016/j.breast.2010.05.015] [PMID: 20561790]
[28]
Lan, Mu. Current status and trends in the treatment and prevention of upper extremity lymphedema in breast reconstruction. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhig, 2018, 2018(04), 247-251.
[29]
Carlson, J.A. Lymphedema and subclinical lymphostasis (microlymphedema) facilitate cutaneous infection, inflammatory dermatoses, and neoplasia: A locus minoris resistentiae. Clin. Dermatol., 2014, 32(5), 599-615.
[http://dx.doi.org/10.1016/j.clindermatol.2014.04.007] [PMID: 25160101]
[30]
Becker, C.; Vasile, J.V.; Levine, J.L.; Batista, B.N.; Studinger, R.M.; Chen, C.M.; Riquet, M. Microlymphatic surgery for the treatment of iatrogenic lymphedema. Clin. Plast. Surg., 2012, 39(4), 385-398.
[http://dx.doi.org/10.1016/j.cps.2012.08.002] [PMID: 23036289]
[31]
Gonzalez, E.A.; Saltzstein, E.C.; Riedner, C.S.; Nelson, B.K. Seroma formation following breast cancer surgery. Breast J., 2003, 9(5), 385-388.
[http://dx.doi.org/10.1046/j.1524-4741.2003.09504.x] [PMID: 12968958]
[32]
Agrawal, A.; Ayantunde, A.A.; Cheung, K.L. Concepts of seroma formation and prevention in breast cancer surgery. ANZ J. Surg., 2006, 76(12), 1088-1095.
[http://dx.doi.org/10.1111/j.1445-2197.2006.03949.x] [PMID: 17199696]
[33]
Docimo, G.; Limongelli, P.; Conzo, G.; Gili, S.; Bosco, A.; Rizzuto, A.; Amoroso, V.; Marsico, S.; Leone, N.; Esposito, A.; Vitiello, C.; Fei, L.; Parmeggiani, D.; Docimo, L. Axillary lymphadenectomy for breast cancer in elderly patients and fibrin glue. BMC Surg., 2013, 13(2)(Suppl. 2), S8.
[http://dx.doi.org/10.1186/1471-2482-13-S2-S8] [PMID: 24266959]
[34]
Gilly, F.N.; François, Y.; Sayag-Beaujard, A.C.; Glehen, O.; Brachet, A.; Vignal, J. Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. Eur. Surg. Res., 1998, 30(6), 439-443.
[http://dx.doi.org/10.1159/000008611] [PMID: 9838238]
[35]
Medl, M.; Mayerhofer, K.; Peters-Engl, C.; Mahrhofer, P.; Huber, S.; Buxbaum, P.; Sevelda, P.; Leodolter, S. The application of fibrin glue after axillary lymphadenectomy in the surgical treatment of human breast cancer. Anticancer Res., 1995, 15(6B), 2843-2845.
[PMID: 8669876]
[36]
Ruggiero, R.; Procaccini, E.; Piazza, P.; Docimo, G.; Iovino, F.; Antoniol, G.; Irlandese, E.; Gili, S.; Lo Schiavo, F. Effectiveness of fibrin glue in conjunction with collagen patches to reduce seroma formation after axillary lymphadenectomy for breast cancer. Am. J. Surg., 2008, 196(2), 170-174.
[http://dx.doi.org/10.1016/j.amjsurg.2007.09.042] [PMID: 18639659]
[37]
Ruggiero, R.; Procaccini, E.; Gili, S.; Cremone, C.; Parmeggiani, D.; Conzo, G.; Docimo, L.; Sparavigna, L.; Gubitosi, A.; Docimo, G.; Sanguinetti, A.; Avenia, N. New trends on fibrin glue in seroma after axillary lymphadenectomy for breast cancer. G. Chir., 2009, 30(6-7), 306-310.
[PMID: 19580713]
[38]
Cipolla, C.; Fricano, S.; Vieni, S.; Graceffa, G.; Licari, G.; Torcivia, A.; Latteri, M.A. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. J. Surg. Oncol., 2010, 101(7), 600-603.
[http://dx.doi.org/10.1002/jso.21531] [PMID: 20461767]
[39]
Johnson, L.; Cusick, T.E.; Helmer, S.D.; Osland, J.S. Influence of fibrin glue on seroma formation after breast surgery. Am. J. Surg., 2005, 189(3), 319-323.
[http://dx.doi.org/10.1016/j.amjsurg.2005.01.004] [PMID: 15792759]
[40]
Carless, P.A.; Henry, D.A. Systematic review and meta-analysis of the use of fibrin sealant to prevent seroma formation after breast cancer surgery. Br. J. Surg., 2006, 93(7), 810-819.
[http://dx.doi.org/10.1002/bjs.5432] [PMID: 16775816]
[41]
Hart, A.M.; Duggal, C.; Pinell-White, X.; Losken, A. A prospective randomized trial of the efficacy of fibrin glue, triamcinolone acetonide, and quilting sutures in seroma prevention after latissimus dorsi breast reconstruction. Plast. Reconstr. Surg., 2017, 139(4), 854e-863e.
[http://dx.doi.org/10.1097/PRS.0000000000003213] [PMID: 28350654]
[42]
Jeon, B.J.; Lee, T.S.; Lim, S.Y.; Pyon, J.K.; Mun, G.H.; Oh, K.S.; Bang, S.I. Risk factors for donor-site seroma formation after immediate breast reconstruction with the extended latissimus dorsi flap: a statistical analysis of 120 consecutive cases. Ann. Plast. Surg., 2012, 69(2), 145-147.
[http://dx.doi.org/10.1097/SAP.0b013e3182259337] [PMID: 21734538]
[43]
Tomita, K.; Yano, K.; Masuoka, T.; Matsuda, K.; Takada, A.; Hosokawa, K. Postoperative seroma formation in breast reconstruction with latissimus dorsi flaps: a retrospective study of 174 consecutive cases. Ann. Plast. Surg., 2007, 59(2), 149-151.
[http://dx.doi.org/10.1097/SAP.0b013e31802c54ef] [PMID: 17667407]
[44]
Delay, E.; Gounot, N.; Bouillot, A.; Zlatoff, P.; Rivoire, M. Autologous latissimus breast reconstruction: a 3-year clinical experience with 100 patients. Plast. Reconstr. Surg., 1998, 102(5), 1461-1478.
[http://dx.doi.org/10.1097/00006534-199810000-00020] [PMID: 9774000]
[45]
Clough, K.B.; Louis-Sylvestre, C.; Fitoussi, A.; Couturaud, B.; Nos, C. Donor site sequelae after autologous breast reconstruction with an extended latissimus dorsi flap. Plast. Reconstr. Surg., 2002, 109(6), 1904-1911.
[http://dx.doi.org/10.1097/00006534-200205000-00020] [PMID: 11994592]
[46]
Mohammad, J.A.; Warnke, P.H.; Stavraky, W. Ultrasound in the diagnosis and management of fluid collection complications following abdominoplasty. Ann. Plast. Surg., 1998, 41(5), 498-502.
[http://dx.doi.org/10.1097/00000637-199811000-00008] [PMID: 9827952]
[47]
Araco, A.; Gravante, G.; Araco, F.; Sorge, R.; Cervelli, V. Postoperative seromas after abdominoplasty: a retrospective analysis of 494 patients and possible risk factors. Plast. Reconstr. Surg., 2009, 123(4), 158e-159e.
[http://dx.doi.org/10.1097/PRS.0b013e31819e5d43] [PMID: 19337077]
[48]
Cavadas, P.C.; Baena-Montilla, P. Progressive late seroma as an uncommon cause of wound dehiscence and expander extrusion. Plast. Reconstr. Surg., 1995, 95(1), 212-213.
[http://dx.doi.org/10.1097/00006534-199501000-00059] [PMID: 7809258]
[49]
Andeweg, C.S.; Schriek, M.J.; Heisterkamp, J.; Roukema, J.A. Seroma formation in two cohorts after axillary lymph node dissection in breast cancer surgery: does timing of drain removal matter? Breast J., 2011, 17(4), 359-364.
[http://dx.doi.org/10.1111/j.1524-4741.2011.01099.x] [PMID: 21679270]
[50]
Lee, K.T.; Mun, G.H. Fibrin sealants and quilting suture for prevention of seroma formation following latissimus dorsi muscle harvest: a systematic review and meta-analysis. Aesthetic Plast. Surg., 2015, 39(3), 399-409.
[http://dx.doi.org/10.1007/s00266-015-0476-x] [PMID: 25808821]
[51]
Dancey, A.L.; Cheema, M.; Thomas, S.S. A prospective randomized trial of the efficacy of marginal quilting sutures and fibrin sealant in reducing the incidence of seromas in the extended latissimus dorsi donor site. Plast. Reconstr. Surg., 2010, 125(5), 1309-1317.
[http://dx.doi.org/10.1097/PRS.0b013e3181d4fb68] [PMID: 20440152]
[52]
Ali, S.N.; Gill, P.; Oikonomou, D.; Sterne, G.D. The combination of fibrin glue and quilting reduces drainage in the extended latissimus dorsi flap donor site. Plast. Reconstr. Surg., 2010, 125(6), 1615-1619.
[http://dx.doi.org/10.1097/PRS.0b013e3181d0ab4d] [PMID: 20517084]
[53]
Bailey, S.H.; Oni, G.; Guevara, R.; Wong, C.; Saint-Cyr, M. Latissimus dorsi donor-site morbidity: the combination of quilting and fibrin sealant reduce length of drain placement and seroma rate. Ann. Plast. Surg., 2012, 68(6), 555-558.
[http://dx.doi.org/10.1097/SAP.0b013e318216b65c] [PMID: 21629082]
[54]
Andree, C.; Munder, B.I.; Behrendt, P.; Hellmann, S.; Audretsch, W.; Voigt, M.; Reis, C.; Beckmann, M.W.; Horch, R.E.; Bach, A.D. Improved safety of autologous breast reconstruction surgery by stabilisation of microsurgical vessel anastomoses using fibrin sealant in 349 free DIEP or fascia-muscle-sparing (fms)-TRAM flaps: a two-centre study. Breast, 2008, 17(5), 492-498.
[http://dx.doi.org/10.1016/j.breast.2008.03.010] [PMID: 18502642]
[55]
Hivelin, M.; Heusse, J.L.; Matar, N.; Lepage, C.; Lantieri, L. Fibrin sealant decreases postoperative drainage in immediate breast reconstruction by deep inferior epigastric perforator flap after mastectomy with axillary dissection. Microsurgery, 2011, 31(1), 18-25.
[http://dx.doi.org/10.1002/micr.20812] [PMID: 20878653]
[56]
Cho, A.B.; Wei, T.H.; Torres, L.R.; Júnior, R.M.; Rugiero, G.M.; Aita, M.A. Fibrin glue application in microvascular anastomosis: comparative study of two free flaps series. Microsurgery, 2009, 29(1), 24-28.
[http://dx.doi.org/10.1002/micr.20554] [PMID: 18942643]

Rights & Permissions Print Cite
Article Metrics
43
2
World Chagas Disease
© 2024 Bentham Science Publishers | Privacy Policy